Author:
Barseem Aya,Ahmed Hytham,El-Shabrawy Yasser,Belal Fathalla
Subject
Spectroscopy,Analytical Chemistry
Reference32 articles.
1. Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes;Augeri;J. Med. Chem.,2005
2. Development and validation of spectrophotometric method for the determination of DPP-4 inhibitor, sitagliptin, in its pharmaceutical preparations;Sekaran;Ecletica Quím.,2010
3. Sensitive liquid chromatography tandem mass spectrometry method for the quantification of sitagliptin, a DPP-4 inhibitor, in human plasma using liquid–liquid extraction;Nirogi;Biomed. Chromatogr.,2008
4. Sitagliptin;Dhillon;Drugs,2010
5. New combination treatments in the management of diabetes: focus on sitagliptin – metformin;Green;Vasc. Health Risk Manag.,2008
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献